Comparison of 18F-fluorodeoxyglucose PET and 68Ga-fibroblast Activation Protein Inhibitor PET in Head and Neck Cancers: A Systematic Review and Meta-analysis.
IF 3.8 2区 医学Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
{"title":"Comparison of <sup>18</sup>F-fluorodeoxyglucose PET and <sup>68</sup>Ga-fibroblast Activation Protein Inhibitor PET in Head and Neck Cancers: A Systematic Review and Meta-analysis.","authors":"Shuhui Huang, Yueqi Wang, Rui Huang","doi":"10.1016/j.acra.2025.02.038","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to compare the diagnostic efficiency of <sup>68</sup>Ga-fibroblast activation protein inhibitor (FAPI) positron emission tomography (PET) and <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) PET in patients with head and neck cancer (HNC).</p><p><strong>Data sources: </strong>PubMed, Embase, Web of Science, and the Cochrane Library were used to perform a systemic search through June 26, 2024.</p><p><strong>Methods: </strong>Studies comparing the diagnostic value of <sup>68</sup>Ga-FAPI PET and <sup>18</sup>F-FDG PET in patients with HNC were included. We performed a bivariate meta-analysis of diagnostic data and a meta-analysis of the quantitative parameters. The summary receiver operating characteristic curve was plotted, and publication bias was evaluated via Egger's test.</p><p><strong>Results: </strong>The meta-analysis included 12 studies on 386 patients with HNC. <sup>68</sup>Ga-FAPI PET had superior pooled sensitivity to <sup>18</sup>F-FDG PET in detecting primary/recurrent tumors and distant metastases in both lesion-based analysis and patient-based analysis. Although the sensitivity of <sup>18</sup>F-FDG PET for detecting lymph node metastases was greater than that of <sup>68</sup>Ga-FAPI PET (0.93 [95% CI 0.83-0.97] vs. 0.82 [95% CI 0.63-0.93]), the specificity of <sup>18</sup>F-FDG PET was lower than that of <sup>68</sup>Ga-FAPI PET (0.36 [95% CI 0.01-0.96] vs. 0.97 [95% CI 0.53-1.00]). In addition, <sup>68</sup>Ga-FAPI PET had a higher pooled mean maximum standardized uptake value for distant metastases (3.28 [95% CI 1.90-4.66]) and a higher pooled mean tumor-to-background ratio for primary/recurrent tumors (1.24 [95% CI 0.44-2.04]) than <sup>18</sup>F-FDG PET.</p><p><strong>Conclusion: </strong>Compared to <sup>18</sup>F-FDG PET, <sup>68</sup>Ga-FAPI PET has superior diagnostic accuracy in HNC lesions. Thus, <sup>68</sup>Ga-FAPI PET may be a better tool for staging and restaging than <sup>18</sup>F-FDG PET in patients with HNC.</p>","PeriodicalId":50928,"journal":{"name":"Academic Radiology","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Academic Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.acra.2025.02.038","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: This study aimed to compare the diagnostic efficiency of 68Ga-fibroblast activation protein inhibitor (FAPI) positron emission tomography (PET) and 18F-fluorodeoxyglucose (18F-FDG) PET in patients with head and neck cancer (HNC).
Data sources: PubMed, Embase, Web of Science, and the Cochrane Library were used to perform a systemic search through June 26, 2024.
Methods: Studies comparing the diagnostic value of 68Ga-FAPI PET and 18F-FDG PET in patients with HNC were included. We performed a bivariate meta-analysis of diagnostic data and a meta-analysis of the quantitative parameters. The summary receiver operating characteristic curve was plotted, and publication bias was evaluated via Egger's test.
Results: The meta-analysis included 12 studies on 386 patients with HNC. 68Ga-FAPI PET had superior pooled sensitivity to 18F-FDG PET in detecting primary/recurrent tumors and distant metastases in both lesion-based analysis and patient-based analysis. Although the sensitivity of 18F-FDG PET for detecting lymph node metastases was greater than that of 68Ga-FAPI PET (0.93 [95% CI 0.83-0.97] vs. 0.82 [95% CI 0.63-0.93]), the specificity of 18F-FDG PET was lower than that of 68Ga-FAPI PET (0.36 [95% CI 0.01-0.96] vs. 0.97 [95% CI 0.53-1.00]). In addition, 68Ga-FAPI PET had a higher pooled mean maximum standardized uptake value for distant metastases (3.28 [95% CI 1.90-4.66]) and a higher pooled mean tumor-to-background ratio for primary/recurrent tumors (1.24 [95% CI 0.44-2.04]) than 18F-FDG PET.
Conclusion: Compared to 18F-FDG PET, 68Ga-FAPI PET has superior diagnostic accuracy in HNC lesions. Thus, 68Ga-FAPI PET may be a better tool for staging and restaging than 18F-FDG PET in patients with HNC.
期刊介绍:
Academic Radiology publishes original reports of clinical and laboratory investigations in diagnostic imaging, the diagnostic use of radioactive isotopes, computed tomography, positron emission tomography, magnetic resonance imaging, ultrasound, digital subtraction angiography, image-guided interventions and related techniques. It also includes brief technical reports describing original observations, techniques, and instrumental developments; state-of-the-art reports on clinical issues, new technology and other topics of current medical importance; meta-analyses; scientific studies and opinions on radiologic education; and letters to the Editor.